-
2024-511508-18-00
9
2026-01-05
Chronic graft versus host disease.
-
2025-521003-52-00
9
2025-12-19
HER2 Expressing Advanced Breast Cancer
-
2025-521155-23-00
4
2025-12-19
Pulmonary Arterial Hypertension
-
2025-521692-31-00
5
2025-12-19
Chronic Primary Immune Thrombocytopenia
-
2025-521382-27-00
10
2025-12-04
Moderately to Severely Active Crohn's Disease
-
2024-511028-15-00
4
2025-11-20
Progressive Multiple Sclerosis
-
2024-514401-54-00
5
2025-11-13
Chronic Primary Immune Thrombocytopenia
-
2024-517553-26-00
5
2025-11-12
Advanced ALK-positive non-small cell lung cancer (NSCLC)
-
2024-518008-33-00
5
2025-11-12
Early Symptomatic Alzheimer’s Disease (MCI to Mild Dementia due to AD)
-
2024-520190-12-00
5
2025-11-10
Breast Cancer: triple negative breast cancer (TNBC) and hormone recept
-
2025-520566-22-00
5
2025-11-10
Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic Breast Ca
-
2024-518365-10-00
5
2025-10-28
Previously Untreated Advanced or Metastatic Non-Squamous Non−Small Cel
-
2025-521188-11-00
5
2025-10-15
Type 2 diabetes
-
2023-509175-16-00
5
2025-10-14
Sickle cell disease
-
2025-520473-40-00
4
2025-09-29
Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
-
2024-513613-12-00
9
2025-09-18
Part A: Healthy volunteers (Part A is not applicable to the EU; for in
-
2024-519814-29-00
4
2025-09-12
Advanced or Metastatic Non-small Cell Lung Cancer
-
2024-516982-35-00
5
2025-09-11
Ovarian Cancer
-
2024-512752-38-00
5
2025-09-09
Adjunctive and maintenance treatment to HCT
-
2024-518154-16-00
5
2025-08-27
non-small cell lung cancer
-
2024-517529-26-00
5
2025-08-04
Chronic Inflammatory Demyelinating Polyneuropathy
-
2023-508050-26-00
3
2025-07-17
AML
-
2024-519262-42-00
4
2025-07-15
NSCLC non-small cell lung cancer
-
2025-520705-12-00
4
2025-06-24
Colitis Ulcerative